[1] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版).中华传染病杂志,2019,37:1-9.
[2] Kakisaka.K,Kojiro Kataoka,Mio Onodera,et al.Alpha-fetoprotein:a biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure.Hepatology Research,2015. 45: p.E12-E20.
[3] Wang X, Shen C, Yang J,et al.Alpha-Fetoprotein as a predictive marker for patients with hepatitis b-related acute-on-chronic liver failure.Can J Gastroenterol Hepatol,2018,2018: 1232785.
[4] 陈应强,庄海,李向永, 等.甲胎蛋白对慢性 HBV 感染后重型肝炎预后的预测价值.广东医学,2015:721-722.
[5] 苗静,吴素琼,郭丽颖等.甲胎蛋白和胆碱酯酶在乙型肝炎病毒相关慢加急性肝衰竭患者中应用价值的研究.中华危重病急救医学,2016,28:257-261.
[6] Fan,Z.Neutrophil-lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system.PLOS ONE,2017,12:p.e0175332.
[7] 赵紫烟,安雪清,史丽等.血清前白蛋白/总胆红素比值对肝衰竭患者预后的预测价值.中国现代医学杂志,2017,27:75-78.
[8] Kumar R,Shalimar,Sharma H,et a1.Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure.Clin Gastroenterol Hepatol,2012,10:925-931.
[9] 李晨,游邵丽,刘鸿凌等.基线MELD、MELD-Na、iMELD 3种模型对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值.中华危重病急救医学,2014.26:539-543.
[10] 莫穆隆,梁柱石,周德玫等.肝衰竭患者的血小板与血清钠及血清肌酐变化比较.中国医师进修杂志,2017.40:72-75.
[11] 周青,谭德明,易钊全等.血清降钙素原、内毒素和常用炎症指标结合MELD评分对慢性重型肝炎预后价值的评价.中南大学学报(医学版),2013,38:388-394.
[12] Maiwall,R.,,Kumar,S.,Chaudhary,A,et al.Serum ferritin predicts early mortality in patients with decompensated cirrhosis.J Hepatol,2014,61:p.43-50.
[13] 章健,黄秀香,田楠楠,等.慢乙肝中度患者的甲状腺指标变化及其相关性分析[J].标记免疫分析与临床,2015,22:782-783.
[14] Maiwall R,Kumar S,.Sarin SK,et al. Reply to: "Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure".J Hepatol,2014,61:p.1447-1448.
[15] 高晓嫱.血清中免疫球蛋白检验在乙型肝炎诊治中的意义国际检验医学杂志,2015,34:358.
[16] Gao Fang-Yuan,Liu Yao,Li Xiao-Shu,et al.Score model for predicting acute-on-chronic liver failure risk in chronic hepatitis B.World Journal of Gastroenterology,2015,21:p.8373.
[17] Malinchoc M,Kamath PS,Gordon FD,et al.A model to predict poor survival in patients undergoing transjugular Intrahepatic portosystemic shunts.Hepatology,2000,31:864-871.
[18] Biggins SW,Kim WR,Terrault NA,et al.Evidence based incorporation of serum sodium concentration into MELD.Gastroenterology,2006,130:1652-1660.
[19] 陈铿,曹欣,郑英等.MELD-Na与CTP评分评估乙型肝炎慢加急性肝衰竭短期预后的对比研究,2015,南方医科大学.第62页.
[20] Lucaa,Aangermayr B,Bertolini G,et al.An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.Liver Transpl,2007,13:1174-1180.
[21] Shi Y,Yang Y,Hu Y,et al.Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults.Hepatology,2015,62:232-243.
[22] 凡小丽,文茂瑶,沈怡等.不同评分系统对失代偿期肝硬化患者短期和中期死亡风险预测能力的比较.临床肝胆病杂志,2017,33:1284-1290.
[23] 蒋晓渠,陈世耀,王慧等.比较CTP评分、CTP分级、MELD评分、iMELD评分对食管静脉曲张破裂出血短期预后的评估.胃肠病学和肝病学杂志,2011,20:240-243.
[24] Martin,K.G.,Simpson,K.J.,Wright,E.C,et al.The sequential organ failure assessment(SOFA)score is prognostically superior to the model for end-stage liver disease(MELD)and MELD variants following paracetamol(acetaminophen)overdose.Alimen Pharmacol Ther,2012, 35:p.705-713.
[25] Dhiman RK,Agrawal S, Gupta T,et al.Chronic liver failure-sequential organ failure assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.World J Gastroenterol,2014,20:14934-14941.
[26] Pan HC, Jenq CC, Tsai MH,et al.Scoring systems for 6-month mortality in critically ill cirrhotic patients:a prospective analysis of chronic liver failure-sequential organ failure assessment score (CLIF-SOFA).Alimen Pharmacol Ther,2014,40:1056-1065.
[27] WU T,LI J,SHAO L,et al.Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure.Gut,2018,67:2181-2191.
[28] Choudhury A,Jindal A,Maiwall R,et al.Liver fail-ure determines the outcome in patients of acute-on-chronic liver failure(ACLF):comparison of APASL ACLF research consortium(AARC)and CLIF-SOFA models.Hepatol Int,2017,11:461-471.
[29] 刘宝荣,方建凯,林明华等.应用人工神经网络评估乙型肝炎慢加急性肝衰竭发生肝性脑病的危险因素.肝脏,2017:1085-1089+1093. |
